[go: up one dir, main page]

AU1799097A - Presentation of antigen, introduced into the cells by stimulation of macropinocytosis - Google Patents

Presentation of antigen, introduced into the cells by stimulation of macropinocytosis

Info

Publication number
AU1799097A
AU1799097A AU17990/97A AU1799097A AU1799097A AU 1799097 A AU1799097 A AU 1799097A AU 17990/97 A AU17990/97 A AU 17990/97A AU 1799097 A AU1799097 A AU 1799097A AU 1799097 A AU1799097 A AU 1799097A
Authority
AU
Australia
Prior art keywords
macropinocytosis
stimulation
antigen
presentation
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU17990/97A
Inventor
Colin Watts
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Dundee
Original Assignee
University of Dundee
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9526269.7A external-priority patent/GB9526269D0/en
Application filed by University of Dundee filed Critical University of Dundee
Publication of AU1799097A publication Critical patent/AU1799097A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/646Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515Animal cells
    • A61K2039/5154Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55516Proteins; Peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU17990/97A 1995-12-21 1996-12-23 Presentation of antigen, introduced into the cells by stimulation of macropinocytosis Abandoned AU1799097A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9526269.7A GB9526269D0 (en) 1995-12-21 1995-12-21 Method
GB9526269 1995-12-21
US64889496A 1996-05-16 1996-05-16
US648894 1996-05-16
PCT/GB1996/003214 WO1997023607A2 (en) 1995-12-21 1996-12-23 Presentation of antigen, introduced into cells by stimulation of macropinocytosis

Publications (1)

Publication Number Publication Date
AU1799097A true AU1799097A (en) 1997-07-17

Family

ID=26308366

Family Applications (1)

Application Number Title Priority Date Filing Date
AU17990/97A Abandoned AU1799097A (en) 1995-12-21 1996-12-23 Presentation of antigen, introduced into the cells by stimulation of macropinocytosis

Country Status (3)

Country Link
EP (1) EP0910632A2 (en)
AU (1) AU1799097A (en)
WO (1) WO1997023607A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005021712A2 (en) * 2003-06-25 2005-03-10 Georgia Tech Research Corporation Modified molecular beacons
US9259483B2 (en) * 2011-11-24 2016-02-16 Positec Power Tools (Suzhou) Co Ltd Peptide sequence design and use thereof for peptide-mediated siRNA delivery

Also Published As

Publication number Publication date
EP0910632A2 (en) 1999-04-28
WO1997023607A3 (en) 1997-09-18
WO1997023607A2 (en) 1997-07-03

Similar Documents

Publication Publication Date Title
AU5316096A (en) Gene therapy by secretory gland expression
AU7478394A (en) Methods for (ex vivo) therapy using peptide-loaded antigen presenting cells for the activation of ctl
AU6095696A (en) Immunogenic peptides of prostate specific antigen
AU5268696A (en) Novel compounds and methods for therapy
AU5393796A (en) Bioreactor
AU7608596A (en) Improved high chair system
AU5333596A (en) 3-benzylamino-2-phenylpiperidines as neurokinin antagonists
AU5930396A (en) Allogeneic cell therapy for cancer following allogeneic stem cell transplantation
AU7739596A (en) Improved hyperbaric chamber
AU4329396A (en) Use of 3,4-diphenylchromans
AU7949394A (en) Reconstituted human antibody against human medulloblastomatous cell
AU2377095A (en) Apparatus for the manufacture of innerspring constructions
AUPN178995A0 (en) Antigen composition
AU5507098A (en) Enhancement of dna immunization through the use of cytokines
AU5168496A (en) Butyryl-tyrosinyl spermine, analogs thereof and methods of preparing and using same
AU6130196A (en) Cell treatment
AU5058196A (en) Process for the preparation of 1,1-difluoroethane
AU4729396A (en) Process for the preparation of 1,2-benzisothiazolin-3-ones
AU6496094A (en) Tumor-associated antigens recognized by t cells and the uses of these antigens
AU7301596A (en) Chair
AU5486396A (en) Process for the preparation of spiroindolines
AU7096496A (en) Process for the preparation of 4-methylenepiperidines
AU1799097A (en) Presentation of antigen, introduced into the cells by stimulation of macropinocytosis
AU2818695A (en) Natural killer cell enhancing factor c
AU8842798A (en) Process for the preparation of ivermectin